Statins of ‘no use for general pediatric lupus population’
November 8th, 2010 - 2:56 pm ICT by ANIWashington, Nov 08 (ANI): Routinely using statins doesn’t provide enough benefit to warrant their regular use in children and adolescents, reports a study.
Lupus is an autoimmune disease that causes widespread inflammation and organ damage. Children with lupus show early signs of atherosclerosis — the fatty tissue buildup that is the precursor to clogged arteries.
Statins were the obvious choice for investigation since they have proven effective at decreasing heart disease incidence in many adult populations.
“We thought every child with lupus should routinely be put on statins,” Laura Schanberg, a professor of pediatrics at Duke University Medical Center, said.
“This study proves that’s not the case. The statins had positive effects on CRP and lipid levels, and they appear to be safe and well tolerated. But their effect on atherosclerosis was not significant enough to warrant routine use,” said Schanberg,
It randomized 221 participants with pediatric lupus (ages 10 to 21) from 21 sites within the Childhood Arthritis and Rheumatology Research Alliance (CARRA) to two groups. One group received atorvastatin (Lipitor), the other received placebo for 36 months.
The researchers used ultrasound techniques to detect thickening of the arterial wall of carotid arteries. They also studied blood lipid levels, inflammation markers including C-reactive protein (CRP), and lupus disease activity measures.
“There are rare long-term risks associated with statins that outweigh the risks of using them routinely without proof of clinically significant benefit,” Schanberg said.
Further analysis is needed to determine whether sub groups of the study participants might derive more benefit from statin therapy.
“We’re not saying statins should never be used in kids with lupus,” she said.
“Rather, we showed that statins should not be routinely prescribed to children with lupus. A lot more information has to go into the decision, and further investigation will help us arrive at a more definitive answer,” she added.
The findings were presented at the American College of Rheumatology meeting in Atlanta. (ANI)
- Statin use may cut risk of colorectal cancer - Oct 19, 2010
- Statin may help fight HIV - Feb 17, 2011
- New technique to identify potential atherosclerosis risk found - Apr 12, 2011
- Low vitamin D worsens lupus: Study - May 08, 2012
- Biomarker can nip hardening of arteries in the bud - Jan 22, 2012
- Statin can prevent strokes, besides lowering lipids - Jan 05, 2012
- 'Statins prevent cancer in heart transplant patients' - May 20, 2012
- Cholesterol-lowering statins 'kill bacteria' - Nov 18, 2010
- Re-engineered toxins can treat asthma, arthritis - Jan 02, 2012
- High consumption of omega-3s 'cuts obesity-related disease risk' - Mar 25, 2011
- Weight loss lowers diabetics' risk of heart attacks - May 04, 2012
- Higher statin doses may not prevent coronary artery disease - Jan 19, 2010
- High fat diet damages arteries earlier than suspected - Apr 04, 2012
- Statins stave off depression in heart patients - Feb 26, 2012
- Ranbaxy approved to make first generic version of Lipitor - Dec 01, 2011
Tags: adult populations, atorvastatin, autoimmune disease, blood lipid levels, c reactive protein, carotid arteries, carra, childhood arthritis, clogged arteries, crp, disease incidence, duke university medical, duke university medical center, fatty tissue, lupus, organ damage, research alliance, study participants, ultrasound techniques, university medical center